Report #2850700

Received Jul 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Headache

Symptom narrative

How to reduce headache; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced headache (Verbatim: How to reduce headache). The outcome of the headache was not reported. It was unknown if the reporter considered the headache to be related to Shingrix. It was unknown if the company considered the headache to be related to Shingrix. Additional Information: GSK Receipt Date: 11-JUL-2025 This case was reported by a patient via interactive digital media. The reporter asked that how to reduce headache.